GLP-1 acts through its receptors, GLP-1R, which is expressed in different tissues, including the pancreas, heart, kidney, adipose, and central nervous system
Contrave isnt one of those meds
The FDA has not approved any transdermal patch delivery system for GLP-1 medications
In endometriosis, impaired endometrial receptivity arises from interconnected mechanisms involving defective decidualization, altered immune cell populations, and a disrupted endometrial environment, collectively contributing to implantation failure
Lilly intends to submit the drug to regulators by the end of 2025, positioning it as the first oral GLP-1 receptor agonist approved specifically for obesity
Avoid buffers above pH 7.5 for extended periods (maleimide hydrolyzes at alkaline pH)